Eton Pharma’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Eton Pharma is a pharmaceutical company that researches, develops and commercializes injectables, oral liquids and ophthalmics. Read more

Eton Pharma is a pharmaceutical company that researches, develops and commercializes injectables, oral liquids and ophthalmics. Read more

Sean Brynjelsen's photo - CEO of Eton Pharma

CEO

Sean Brynjelsen

CEO Approval Rating

87/100

Founded:

2017

Status:

PublicNASDAQETON

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Innovus Pharma is Eton Pharma's #1 competitor. Innovus Pharma is a Private company that was founded in 2010 in San Diego, California. Innovus Pharma is in the Pharmaceuticals industry. Compared to Eton Pharma, Innovus Pharma has 6 more employees.

Sienna Biopharmaceuticals is seen as one of Eton Pharma's biggest rivals. Sienna Biopharmaceuticals was founded in Westlake Village, California} in 2010. Sienna Biopharmaceuticals competes in the Biotechnology field. Compared to Eton Pharma, Sienna Biopharmaceuticals generates $422K more revenue.

ImprimisRx is one of Eton Pharma's top competitors. ImprimisRx is headquartered in San Diego, California, and was founded in 2011. ImprimisRx is in the Pharmaceuticals field. ImprimisRx generates 8,852% the revenue of Eton Pharma.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Suneva Medical a competitor of Eton Pharma?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$ < 1M

Eton Pharma's revenue is the ranked 8th among it's top 10 competitors. The top 10 competitors average 22.1M. Over the last three quarters, Eton Pharma's revenue has decreased by 95.6%. Specifically, in Q2 2020's revenue was $ < 1M; in Q1 2020, it was $ < 1M; in Q4 2019, it was $ < 1M.

Acquisitions

No recent acquisitions found related to Eton Pharma

Eton Pharma Funding History

$20M$62.3M$72.3M$72.7M

Since Eton Pharma was founded in 2017, it has participated in 5 rounds of funding. In total Eton Pharma has raised $72.7M. Eton Pharma's last funding round was on May 2020 for a total of $360.8K

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt - PPP (CARES Act)
May 2020
$360.8K
Debt
Nov 2019
$10M
IPO
Nov 2018
$20.7M

IPO
Nov 2018
$21.6M
-
Series A
Jun 2017
$20M
-

Total Funding: $72.7M

Since Eton Pharma was founded in 2017, it has participated in 5 rounds of funding. In total Eton Pharma has raised $72.7M. Eton Pharma's last funding round was on May 2020 for a total of $360.8K

Investments

No recent investments found related to Eton Pharma

Eton Pharma News

October 6, 2020Zolmax News

Eton Pharmaceuticals Inc (NASDAQ:ETON) Expected to Post FY2020 Earnings of ($1.24) Per Share

Eton Pharmaceuticals Inc (NASDAQ:ETON) - Equities researchers at B.Riley Securit raised their FY2020 ... See more »
October 6, 2020Micro Small Cap

Eton Pharmaceuticals Submits New Drug Application to the FDA for Topiramate Oral Solution (ET-101)

- Application Submitted for the Treatment of Partial-Onset Seizures and Migraine - Eton's Patent-Pend... See more »
October 1, 2020Drug Store News

Eton gets FDA green light for Alkindi Sprinkle

Eton's Alkindi Sprinkle is the first and only FDA-approved granular hydrocortisone formulation for ad... See more »
September 30, 2020Benzinga

Eton Pharmaceuticals

During Q2, Eton Pharmaceuticals (NASDAQ: ETON) brought in sales totaling $20.00 thousand. However, ea... See more »
September 30, 2020VisionMonday

FDA Approves Bausch + Lomb's Alaway, the First OTC Preservative-Free Eye Drop Approved for Treating Itchy Eyes Associated With Allergies

LAVAL, Quebec and DEER PARK, Ill.-Bausch Health Companies Inc. (NYSE/TSX: BHC), Bausch + Lomb and Eto... See more »

Eton Pharma Press Releases

August 11, 2020GlobalNewswire

Eton Pharmaceuticals Provides Update on the FDA Review of EM-100

DEER PARK, Ill., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specia... See more »
July 30, 2020GlobeNewswire

Eton Pharmaceuticals Submits New Drug Application to the FDA for Zonisamide Oral Suspension (ET-104)

- Application Submitted for the Treatment of Partial Seizures in Epilepsy Patients... See more »
February 13, 2020GlobeNewswire

Eton Pharmaceuticals to Present at the 9th Annual SVB Leerink Healthcare Conference

DEER PARK, Ill., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a speci... See more »
November 14, 2019GlobeNewswire

Eton Pharmaceuticals Announces Third Quarter Financial Results and Highlights Business Progress

DEER PARK, Ill., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specia... See more »
September 3, 2019GlobalNewswire

Eton Pharmaceuticals to Participate in Lake Street 3rd Annual Best Ideas Growth Conference

DEER PARK, Ill., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a spec... See more »
May 15, 2019GlobeNewswire

Eton Pharmaceuticals to Present at 20th Annual B. Riley FBR Investor Conference

DEER PARK, Ill., May 15, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specia... See more »
May 7, 2019GlobeNewswire

Eton Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Business Progress

- Four Products Currently Under Review with the FDA -... See more »

Headquarters

21925 W Field Pkwy Suite 235

Deer Park, Illinois60010

847-787-7361

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Eton Pharma is a pharmaceutical company that researches, develops and commercializes injectables, oral liquids and ophthalmics. Eton Pharma was founded in 2017. Eton Pharma's headquarters is located in Deer Park, Illinois, USA 60010. It has raised 72....

CEO

Eton Pharma's CEO, Sean Brynjelsen, currently has an approval rating of 87%. Eton Pharma's primary competitors are Innovus Pharma, Sienna Biopharmaceuticals & ImprimisRx.

Website

etonpharma.com

Frequently Asked Questions about Eton Pharma

  1. When was Eton Pharma founded?

    Eton Pharma was founded in 2017
  2. Who is Eton Pharma's CEO?

    Eton Pharma's CEO is Sean Brynjelsen
  3. How much revenue does Eton Pharma generate?

    Eton Pharma generates $ < 1M in revenue
  4. How much funding does Eton Pharma have?

    Eton Pharma has historically raised $72.7M in funding
  1. Where is Eton Pharma's headquarters?

    Eton Pharma's headquarters is in Deer Park Illinois, USA
  2. How many employees does Eton Pharma have?

    Eton Pharma has 15 employees
  3. What sector does Eton Pharma operate in?

    Eton Pharma is in Health Care Supplies
  4. Who are Eton Pharma's competitors?

    Eton Pharma's top competitors are Innovus Pharma, Sienna Biopharmaceuticals, ImprimisRx